LAGUNA NIGUEL, Calif.--(BUSINESS WIRE)--Aeolus Pharmaceuticals, Inc. (OTCBB:AOLS) announced today financial results for three months ended June 30, 2007. Aeolus reported a net loss attributable to common stockholders of $509,000, or $0.02 per share, for the three months ended June 30, 2007, compared to a net loss attributable to common stockholders of $3,178,000, or $0.17 per share, for the three months ended June 30, 2006. The higher net loss for the quarter ended June 2006 principally reflects a $2.2 million charge associated with an increase in the fair value of common stock warrants. The loss from operations during the quarter improved from $943,000 in the quarter ended June 2006 to $512,000 in the quarter ended June 2007.
